Literature DB >> 8102015

Nursing considerations in paclitaxel (Taxol) administration.

B G Lubejko1, S E Sartorius.   

Abstract

The administration of paclitaxel (TAXOL) presents some challenges unique among chemotherapeutic agents. Information published and presented to date has focused primarily on the most threatening and clinically significant aspects of paclitaxel administration and resultant side effects. However, there are a number of other issues that, while not as acutely dangerous, can be very significant to the success of paclitaxel therapy and to those medical, pharmacy, and nursing personnel involved in drug administration and patient management. This review will focus on the collaborative role of the nurse in the recognition and prevention of side effects related to paclitaxel therapy. A nursing plan of care describes the pertinent paclitaxel toxicities and suggests interventions related to patient care issues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102015

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  2 in total

1.  Paclitaxel-induced cutaneous toxicity.

Authors:  T Berghmans; J Klastersky
Journal:  Support Care Cancer       Date:  1995-05       Impact factor: 3.603

Review 2.  A review of clinical experience with paclitaxel extravasations.

Authors:  Brad L Stanford; Fred Hardwicke
Journal:  Support Care Cancer       Date:  2003-03-27       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.